News & Press

    Deep Knowledge Investing – A Conversation with Jim Osman of The Edge

    Please join Gary Brode of Deep Knowledge Investing for a discussion with Jim Osman of The Edge regarding special situations investing. Jim will discuss how his firm identifies attractive special situation ideas as well as a couple of his favorite current ideas. Recommended viewing for anyone interested in catalyst-driven investing.

    Continue reading the full article…

    MoneyShow’s 2021 Mid-Year Top Picks

    In 2021’s mid-year update, The MoneyShow has featured two of Jim Osman and The Edge’s top conviction ideas – Harley-Davidson, Inc. (HOG) and IAC/InterActiveCorp (IAC). See inside for more details.

    Continue reading the full article…

    Merck’s New Spinoff Organon Shows How Women’s Health Can Provide Fertile Ground For Investment. Here’s Why.

    It may be 2021, but the issue of women’s health – especially reproductive rights, birth control and fertility issues – is one which still provokes heated debate and makes headlines around the world. Considering the global women’s health market is predicted to be worth $50 billion by 2025, it seems somewhat ironic that one of the more silent voices tends to be that of Big Pharma.

    Continue reading the full article…

    How You Can Save The Planet And Still Make Money. Here Are 5 Stocks To Consider As Investments.

    The word “green” is never far from the headlines right now. Talk to any Gen Z’er or millennial and they will list the ways we need to do better for our planet. They’re not wrong, but the kind of “green” Wall Street gets excited about is the color of our dollar bills. Until now, that is. Here at The Edge, we’ve been wondering if it’s possible to save the planet and still make money.

    Continue reading the full article…

    A Buried Scandal, Shedding Of Assets, And Forthcoming Spinoff Means Substantial Upside For Bausch Health

    Having a troubled past under the name Valeant, Bausch Health Companies (BHC) saw its leverage balloon. The stock price fell over 90% from its high and forced the company to make major changes including a name change, shedding assets to reduce debt, and an upcoming Spinoff of its eye health segment.

    Continue reading the full article…

    Why The FAANG Stocks Could Be Your Next 50% Upside Bet

    After a year in which the world has become even more reliant on the tech giants, it looks like FAANGs are set to get an even bigger bite of the cherry – as analysis from The Edge daringly predicts.

    Continue reading the full article…

    How to Make a Return in Volatile Markets with an Event Driven Strategy

    On April 6, 2021, The Edge CEO & Founder Jim Osman joined the MoneyShow Virtual Expo to discuss how value catalyst ideas help investors to make returns in volatile markets, as well as highlighting a major call for break-ups at leading tech firms. Please see below for the full recording of the presentation. The slides are available on request.

    Continue reading the full article…

    The SPAC Craze Reaches China

    Wall Streetʼs latest craze for SPACs has reached a new frontier: China.

    Continue reading the full article…

    Archegos Stocks Start Uphill Climb After Block Trades

    Stocks sold in an extraordinary torrent of recent block trades are poised for further selling pressure in the weeks ahead.

    Continue reading the full article…

    MoneyShow Top Picks – Insiders Step Up at Dun & Bradstreet

    In November 2020, insiders CEO Anthony Jabbour and CFO Bryan Hipsher bought shares at the mid-$26 level. Then, on February 11, 2021, both Jabbour (spending $998K) and Hipsher (spending $116K) bought again, this time at the mid-$23 level.

    Continue reading the full article…